Aggretin, a Heterodimeric C-type Lectin from Calloselasma rhodostoma (Malayan Pit Viper), Stimulates Platelets by Binding to α2β1 Integrin and Glycoprotein Ib, Activating Syk and Phospholipase Cγ2, but Does Not Involve the Glycoprotein VI/Fc Receptor γ Chain Collagen Receptor

Alexei Navdaev, Jeannine M. Clemetson, János Polgár, Beate E. Kehrel, Martin Glauner, Edith Magnenat, Timothy N. C. Wells, Kenneth J. Clemetson

Journal of Biological Chemistry · 2001 · 75 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

Aggretin, a potent platelet activator, was isolated from Calloselasma rhodostoma venom, and 30-amino acid N-terminal sequences of both subunits were determined. Aggretin belongs to the heterodimeric snake C-type lectin family and is thought to activate platelets by binding to platelet glycoprotein α2β1. We now show that binding to glycoprotein (GP) Ib is also required. Aggretin-induced platelet activation was inhibited by a monoclonal antibody to GPIb as well as by antibodies to α2β1. Binding of both of these platelet receptors to aggretin was confirmed by affinity chromatography. No binding of other major platelet membrane glycoproteins, in particular GPVI, to aggretin was detected. Aggretin also activates platelets from Fc receptor γ chain (Fcγ)-deficient mice to a greater extent than those from normal control mice, showing that it does not use the GPVI/Fcγ pathway. Platelets from Fcγ-deficient mice expressed fibrinogen receptors normally in response to collagen, although they did not aggregate, indicating that these platelets may partly compensate via other receptors including α2β1 or GPIb for the lack of the Fcγ pathway. Signaling by aggretin involves a dose-dependent lag phase followed by rapid tyrosine phosphorylation of a number of proteins. Among these are p72SYK, p125FAK, and PLCγ2, whereas, in comparison with collagen and convulxin, the Fcγ subunit neither is phosphorylated nor coprecipitates with p72SYK. This supports an independent, GPIb- and integrin-based pathway for activation of p72SYK not involving the Fcγ receptor. Aggretin, a potent platelet activator, was isolated from Calloselasma rhodostoma venom, and 30-amino acid N-terminal sequences of both subunits were determined. Aggretin belongs to the heterodimeric snake C-type lectin family and is thought to activate platelets by binding to platelet glycoprotein α2β1. We now show that binding to glycoprotein (GP) Ib is also required. Aggretin-induced platelet activation was inhibited by a monoclonal antibody to GPIb as well as by antibodies to α2β1. Binding of both of these platelet receptors to aggretin was confirmed by affinity chromatography. No binding of other major platelet membrane glycoproteins, in particular GPVI, to aggretin was detected. Aggretin also activates platelets from Fc receptor γ chain (Fcγ)-deficient mice to a greater extent than those from normal control mice, showing that it does not use the GPVI/Fcγ pathway. Platelets from Fcγ-deficient mice expressed fibrinogen receptors normally in response to collagen, although they did not aggregate, indicating that these platelets may partly compensate via other receptors including α2β1 or GPIb for the lack of the Fcγ pathway. Signaling by aggretin involves a dose-dependent lag phase followed by rapid tyrosine phosphorylation of a number of proteins. Among these are p72SYK, p125FAK, and PLCγ2, whereas, in comparison with collagen and convulxin, the Fcγ subunit neither is phosphorylated nor coprecipitates with p72SYK. This supports an independent, GPIb- and integrin-based pathway for activation of p72SYK not involving the Fcγ receptor. glycoprotein phospholipase Cγ2 monoclonal antibody Fc receptor γ chain fluorescein isothiocyanate polyvinylidene difluoride polyacrylamide gel electrophoresis high pressure liquid chromatography Platelet-collagen interactions are integral to primary hemostasis (1Kehrel B. Semin Thromb. Hemostasis. 1995; 21: 123-129Crossref PubMed Scopus (51) Google Scholar, 2Moroi M. Jung S.M. Thromb. Haemostasis. 1997; 78: 439-444Crossref PubMed Scopus (106) Google Scholar). Resting platelets using several receptors adhering to subendothelium of damaged blood vessels are activated and spread to provide finally a new nonthrombogenic surface until binding and with collagen, is to the platelet high that it via other receptors M. M. Thromb. Haemostasis. PubMed Scopus Google Scholar, M. Jung S.M. M. 1997; PubMed Google Scholar). This that of the in 1995; PubMed Scopus Google Scholar). receptor is the α2β1 is for the platelet to collagen in the subendothelium Thromb. Haemostasis. 1995; PubMed Scopus Google and for to the platelet to the receptor from the membrane by the that it to the of and the of new receptors the platelet surface Google as well as in other receptors as the fibrinogen is for and α2β1 also in to the platelet M. 1997; PubMed Google Scholar, M. PubMed Scopus Google in with platelet receptor GPVI/Fcγ as a major collagen receptor for platelet activation M. Jung S.M. M. PubMed Scopus Google Scholar, M. M. 1997; PubMed Scopus Google Scholar, M. M. 1997; PubMed Scopus Google Scholar). with platelets of these receptors or and platelet to subendothelium or collagen is PubMed Scopus Google Scholar, M. PubMed Scopus Google is the of the receptor is to of of platelet activation does not provide the the of of these that to and activate platelets via receptor are a C-type lectin from the of the activates platelets by binding to and the GPVI/Fcγ receptor M. 1997; PubMed Scopus Google Scholar). other snake are potent platelet and may via of including from Thromb. Haemostasis. PubMed Scopus Google and aggretin from Calloselasma rhodostoma 1995; PubMed Scopus Google to α2β1 platelets as receptor. We isolated a from rhodostoma that is a platelet This is aggretin as by 1995; PubMed Scopus Google the of subunits PubMed Scopus Google and in aggretin it also belongs to the snake C-type lectin C-type lectin from the was PubMed Scopus Google with N-terminal sequences to those of it was to of platelets was PubMed Scopus Google Scholar, M. PubMed Scopus Google showing that with the of α2β1 the platelet the other B. PubMed Scopus Google that does not to a α2β1 We now show that aggretin activates platelets via with GPIb as well as GPVI/Fcγ is not required. This via GPIb and also to activation of platelets via from the rhodostoma that activate and it was that of or via α2β1 1995; PubMed Scopus Google Scholar). Aggretin was and the acid was PubMed Scopus Google Scholar). We isolated a from rhodostoma that N-terminal sequences of and to This a of with subunits of and by gel a This that subunits of the are by and that to Aggretin platelets in a dose-dependent with a lag phase as 1995; PubMed Scopus Google 1995; PubMed Scopus Google Scholar, PubMed Scopus Google the that aggretin via the α2β1 receptor. We confirmed that aggretin to α2β1 that it to GPIb as GPIb in activation of platelets via aggretin was by affinity chromatography and of platelet using an monoclonal monoclonal antibody inhibited platelet as well as in monoclonal antibodies GPIb and did not platelet This that the is to the as the for the PubMed Google Scholar). GPIb and in to receptors to aggretin the platelet was in the of or the platelet was with were not to showing that are for aggretin interactions with platelet is not are for the of aggretin or they are for receptors to a that is by and PubMed Scopus Google isolated a C-type lectin that activates platelets from of rhodostoma that they did not an activation that it was not via N-terminal sequences that they are with the and of the that the of α2β1 is in the platelet with and of in platelets activation with PubMed Scopus Google Scholar, M. PubMed Scopus Google Scholar). by a that does not to a α2β1 rhodostoma C-type of and with sequences than those of aggretin or to the and binding to collagen B. PubMed Scopus Google lack of of GPIb as a receptor for aggretin or was the of monoclonal antibodies or to platelet and PubMed Scopus Google show an in the lag phase response to in the of and the of was also We also that a platelet to of aggretin not monoclonal antibodies that aggretin were and 1995; PubMed Scopus Google Scholar). the binding for aggretin GPIb partly with the not with the of or the other the binding as is a well monoclonal antibody to GPIb with in the PubMed Google that not binding Thromb. PubMed Scopus Google and to of the that the did not aggretin binding to GPIb the did not to the of that the for collagen α2β1 and GPVI/Fcγ are was that α2β1 is an GPVI/Fcγ is the activation receptor for collagen, although is M. M. 1997; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, PubMed Scopus (51) Google Scholar, B. M. M. PubMed Google Scholar). a is via Fcγ to activate p72SYK and B. M. M. PubMed Google Scholar, 1995; PubMed Scopus Google Scholar, M. 1997; PubMed Google a C-type lectin from GPVI/Fcγ to activate platelets via a tyrosine phosphorylation pathway M. 1997; PubMed Scopus Google Scholar). or not aggretin the GPVI/Fcγ the of aggretin platelets from mice were with those normal platelets binding of fibrinogen was to the activation of as a of platelet with convulxin, a the of platelets with a activation of the control the platelets were not activated with the Fcγ-deficient platelets those by PubMed Scopus Google as well as with and platelets B. M. M. PubMed Google and that via M. 1997; PubMed Scopus Google Scholar). the of platelets from both of mice although the normal platelets the Fcγ-deficient platelets that is expressed or that via these receptors is by the of the Fcγ pathway. of platelet also in response to of both the Fcγ-deficient platelets and the normal platelets to collagen were that activation was in were not neither Fcγ-deficient nor platelets B. M. M. PubMed Google to a from GPVI/Fcγ is for the response to with as well as with antibodies not confirmed the Fcγ-deficient of these and PubMed Scopus Google that an in activation of platelets via with antibodies to α2β1. platelets not PubMed Scopus Google it is that receptor is in platelet activation by Fcγ-deficient platelets that they show to collagen M. 1997; PubMed Scopus Google including a activation of p72SYK and the of the is not to a these M. 1997; PubMed Scopus Google did not to collagen with the Fcγ-deficient the of platelets from a with also Fcγ M. M. 1997; PubMed Scopus Google the platelets also to collagen than normal platelets B. M. M. PubMed Google Scholar). was that the response of platelets to collagen to interactions with M. PubMed Scopus Google that of Fcγ-deficient platelets and that to a affinity binding to α2β1 was not inhibited by M. PubMed Scopus Google Scholar). B. PubMed Scopus Google binding to α2β1 in an or in with α2β1 binding to of aggretin and are or with the N-terminal sequences is not platelets by was to platelets with convulxin, the activation of is a of the of M. 1997; PubMed Scopus Google in the activation of was by and is a primary of the aggretin and α2β1 and is α2β1 is or to activated by to This is to with collagen of sequences that with the PubMed Scopus Google is the for interactions in primary it was that the platelet α2β1 and is activated via interactions with platelet activation via GPVI/Fcγ may to α2β1 to it to to of platelets to the the may high it may the receptor that platelet activation via to collagen to α2β1 of a of activation from the with the platelets from the collagen is to a other collagen including may in platelet activation pathway by both collagen and was to phosphorylation of to activation of p72SYK and of for α2β1 in activation of of by was also by using antibodies and PubMed Scopus Google and 1997; PubMed Google that α2β1 via of a these are by the use of collagen as interactions with than receptor or by the use of antibodies a of was that aggretin or may provide a for via α2β1. aggretin to both α2β1 and GPIb the the of other receptors in of α2β1 it as collagen is aggretin is an with than binding for platelet that binding and of α2β1 may not to activate and GPIb or the of is to of activation with activation of p72SYK and of not Fcγ with p72SYK. of a for Fcγ in the platelet response to aggretin supports the using platelets from Fcγ-deficient mice the activation response to aggretin was than that with platelets from control Aggretin, by and α2β1 and a response in This supports a major for α2β1 in platelet activation as binding to and activated platelets S.M. M. PubMed Scopus (106) Google although is a binding to is in activated the of collagen is a for GPVI/Fcγ in platelets in binding collagen not the platelet response to collagen, α2β1 with GPVI/Fcγ and and the response to receptor. This is in the of the platelet response to with α2β1 a number of to to activated by from other receptors to and fibrinogen platelets to and activated by a surface PubMed Scopus Google a in the of to activation of Fcγ the for is not 1997; PubMed Scopus Google Scholar). Aggretin of α2β1 and GPIb to a pathway that may to several of aggretin as a platelets via α2β1 and GPIb of of the from these with for as M. 1997; PubMed Scopus Google or 1995; PubMed Scopus Google it provide the to these major receptors in platelet Platelet-collagen interactions are integral to primary hemostasis (1Kehrel B. Semin Thromb. Hemostasis. 1995; 21: 123-129Crossref PubMed Scopus (51) Google Scholar, 2Moroi M. Jung S.M. Thromb. Haemostasis. 1997; 78: 439-444Crossref PubMed Scopus (106) Google Scholar). Resting platelets using several receptors adhering to subendothelium of damaged blood vessels are activated and spread to provide finally a new nonthrombogenic surface until binding and with collagen, is to the platelet high that it via other receptors M. M. Thromb. Haemostasis. PubMed Scopus Google Scholar, M. Jung S.M. M. 1997; PubMed Google Scholar). This that of the in 1995; PubMed Scopus Google Scholar). receptor is the α2β1 is for the platelet to collagen in the subendothelium Thromb. Haemostasis. 1995; PubMed Scopus Google and for to the platelet to the receptor from the membrane by the that it to the of and the of new receptors the platelet surface Google as well as in other receptors as the fibrinogen is for and α2β1 also in to the platelet M. 1997; PubMed Google Scholar, M. PubMed Scopus Google in with platelet receptor GPVI/Fcγ as a major collagen receptor for platelet activation M. Jung S.M. M. PubMed Scopus Google Scholar, M. M. 1997; PubMed Scopus Google Scholar, M. M. 1997; PubMed Scopus Google Scholar). with platelets of these receptors or and platelet to subendothelium or collagen is PubMed Scopus Google Scholar, M. PubMed Scopus Google Scholar). is the of the receptor is to of of platelet activation does not provide the the of of these that to and activate platelets via receptor are a C-type lectin from the of the activates platelets by binding to and the GPVI/Fcγ receptor M. 1997; PubMed Scopus Google Scholar). other snake are potent platelet and may via of including from Thromb. Haemostasis. PubMed Scopus Google and aggretin from Calloselasma rhodostoma 1995; PubMed Scopus Google to α2β1 platelets as receptor. We isolated a from rhodostoma that is a platelet This is aggretin as by 1995; PubMed Scopus Google the of subunits PubMed Scopus Google and in aggretin it also belongs to the snake C-type lectin C-type lectin from the was PubMed Scopus Google with N-terminal sequences to those of it was to of platelets was PubMed Scopus Google Scholar, M. PubMed Scopus Google showing that with the of α2β1 the platelet the other B. PubMed Scopus Google that does not to a α2β1 We now show that aggretin activates platelets via with GPIb as well as GPVI/Fcγ is not required. This via GPIb and also to activation of platelets via from the rhodostoma that activate and it was that of or via α2β1 1995; PubMed Scopus Google Scholar). Aggretin was and the acid was PubMed Scopus Google Scholar). We isolated a from rhodostoma that N-terminal sequences of and to This a of with subunits of and by gel a This that subunits of the are by and that to Aggretin platelets in a dose-dependent with a lag phase as 1995; PubMed Scopus Google 1995; PubMed Scopus Google Scholar, PubMed Scopus Google the that aggretin via the α2β1 receptor. We confirmed that aggretin to α2β1 that it to GPIb as GPIb in activation of platelets via aggretin was by affinity chromatography and of platelet using an monoclonal monoclonal antibody inhibited platelet as well as in monoclonal antibodies GPIb and did not platelet This that the is to the as the for the PubMed Google Scholar). GPIb and in to receptors to aggretin the platelet was in the of or the platelet was with were not to showing that are for aggretin interactions with platelet is not are for the of aggretin or they are for receptors to a that is by and PubMed Scopus Google isolated a C-type lectin that activates platelets from of rhodostoma that they did not an activation that it was not via N-terminal sequences that they are with the and of the that the of α2β1 is in the platelet with and of in platelets activation with PubMed Scopus Google Scholar, M. PubMed Scopus Google Scholar). by a that does not to a α2β1 rhodostoma C-type of and with sequences than those of aggretin or to the and binding to collagen B. PubMed Scopus Google lack of of GPIb as a receptor for aggretin or was the of monoclonal antibodies or to platelet and PubMed Scopus Google show an in the lag phase response to in the of and the of was also We also that a platelet to of aggretin not monoclonal antibodies that aggretin were and 1995; PubMed Scopus Google Scholar). the binding for aggretin GPIb partly with the not with the of or the other the binding as is a well monoclonal antibody to GPIb with in the PubMed Google that not binding Thromb. PubMed Scopus Google and to of the that the did not aggretin binding to GPIb the did not to the of that the for collagen α2β1 and GPVI/Fcγ are was that α2β1 is an GPVI/Fcγ is the activation receptor for collagen, although is M. M. 1997; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, PubMed Scopus (51) Google Scholar, B. M. M. PubMed Google Scholar). a is via Fcγ to activate p72SYK and B. M. M. PubMed Google Scholar, 1995; PubMed Scopus Google Scholar, M. 1997; PubMed Google a C-type lectin from GPVI/Fcγ to activate platelets via a tyrosine phosphorylation pathway M. 1997; PubMed Scopus Google Scholar). or not aggretin the GPVI/Fcγ the of aggretin platelets from mice were with those normal platelets binding of fibrinogen was to the activation of as a of platelet with convulxin, a the of platelets with a activation of the control the platelets were not activated with the Fcγ-deficient platelets those by PubMed Scopus Google as well as with and platelets B. M. M. PubMed Google and that via M. 1997; PubMed Scopus Google Scholar). the of platelets from both of mice although the normal platelets the Fcγ-deficient platelets that is expressed or that via these receptors is by the of the Fcγ pathway. of platelet also in response to of both the Fcγ-deficient platelets and the normal platelets to collagen were that activation was in were not neither Fcγ-deficient nor platelets B. M. M. PubMed Google to a from GPVI/Fcγ is for the response to with as well as with antibodies not confirmed the Fcγ-deficient of these and PubMed Scopus Google that an in activation of platelets via with antibodies to α2β1. platelets not PubMed Scopus Google it is that receptor is in platelet activation by Fcγ-deficient platelets that they show to collagen M. 1997; PubMed Scopus Google including a activation of p72SYK and the of the is not to a these M. 1997; PubMed Scopus Google did not to collagen with the Fcγ-deficient the of platelets from a with also Fcγ M. M. 1997; PubMed Scopus Google the platelets also to collagen than normal platelets B. M. M. PubMed Google Scholar). was that the response of platelets to collagen to interactions with M. PubMed Scopus Google that of Fcγ-deficient platelets and that to a affinity binding to α2β1 was not inhibited by M. PubMed Scopus Google Scholar). B. PubMed Scopus Google binding to α2β1 in an or in with α2β1 binding to of aggretin and are or with the N-terminal sequences is not platelets by was to platelets with convulxin, the activation of is a of the of M. 1997; PubMed Scopus Google in the activation of was by and is a primary of the aggretin and α2β1 and is α2β1 is or to activated by to This is to with collagen of sequences that with the PubMed Scopus Google is the for interactions in primary it was that the platelet α2β1 and is activated via interactions with platelet activation via GPVI/Fcγ may to α2β1 to it to to of platelets to the the may high it may the receptor that platelet activation via to collagen to α2β1 of a of activation from the with the platelets from the collagen is to a other collagen including may in platelet activation pathway by both collagen and was to phosphorylation of to activation of p72SYK and of for α2β1 in activation of of by was also by using antibodies and PubMed Scopus Google and 1997; PubMed Google that α2β1 via of a these are by the use of collagen as interactions with than receptor or by the use of antibodies a of was that aggretin or may provide a for via α2β1. aggretin to both α2β1 and GPIb the the of other receptors in of α2β1 it as collagen is aggretin is an with than binding for platelet that binding and of α2β1 may not to activate and GPIb or the of is to of activation with activation of p72SYK and of not Fcγ with p72SYK. of a for Fcγ in the platelet response to aggretin supports the using platelets from Fcγ-deficient mice the activation response to aggretin was than that with platelets from control Aggretin, by and α2β1 and a response in This supports a major for α2β1 in platelet activation as binding to and activated platelets S.M. M. PubMed Scopus (106) Google although is a binding to is in activated the of collagen is a for GPVI/Fcγ in platelets in binding collagen not the platelet response to collagen, α2β1 with GPVI/Fcγ and and the response to receptor. This is in the of the platelet response to with α2β1 a number of to to activated by from other receptors to and fibrinogen platelets to and activated by a surface PubMed Scopus Google a in the of to activation of Fcγ the for is not 1997; PubMed Scopus Google Scholar). Aggretin of α2β1 and GPIb to a pathway that may to several of aggretin as a platelets via α2β1 and GPIb of of the from these with for as M. 1997; PubMed Scopus Google or 1995; PubMed Scopus Google it provide the to these major receptors in platelet from the rhodostoma that activate and it was that of or via α2β1 1995; PubMed Scopus Google Scholar). Aggretin was and the acid was PubMed Scopus Google Scholar). We isolated a from rhodostoma that N-terminal sequences of and to This a of with subunits of and by gel a This that subunits of the are by and that to Aggretin platelets in a dose-dependent with a lag phase as 1995; PubMed Scopus Google Scholar). 1995; PubMed Scopus Google Scholar, PubMed Scopus Google the that aggretin via the α2β1 receptor. We confirmed that aggretin to α2β1 that it to GPIb as GPIb in activation of platelets via aggretin was by affinity chromatography and of platelet using an monoclonal monoclonal antibody inhibited platelet as well as in monoclonal antibodies GPIb and did not platelet This that the is to the as the for the PubMed Google Scholar). GPIb and in to receptors to aggretin the platelet was in the of or the platelet was with were not to showing that are for aggretin interactions with platelet is not are for the of aggretin or they are for receptors to a that is by and PubMed Scopus Google isolated a C-type lectin that activates platelets from of rhodostoma that they did not an activation that it was not via N-terminal sequences that they are with the and of the that the of α2β1 is in the platelet with and of in platelets activation with PubMed Scopus Google Scholar, M. PubMed Scopus Google Scholar). by a that does not to a α2β1 rhodostoma C-type of and with sequences than those of aggretin or to the and binding to collagen B. PubMed Scopus Google Scholar). lack of of GPIb as a receptor for aggretin or was the of monoclonal antibodies or to platelet and PubMed Scopus Google show an in the lag phase response to in the of and the of was also We also that a platelet to of aggretin not monoclonal antibodies that aggretin were and 1995; PubMed Scopus Google Scholar). the binding for aggretin GPIb partly with the not with the of or the other the binding as is a well monoclonal antibody to GPIb with in the PubMed Google that not binding Thromb. PubMed Scopus Google and to of the that the did not aggretin binding to GPIb the did not to the of that the for collagen α2β1 and GPVI/Fcγ are was that α2β1 is an GPVI/Fcγ is the activation receptor for collagen, although is M. M. 1997; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, PubMed Scopus (51) Google Scholar, B. M. M. PubMed Google Scholar). a is via Fcγ to activate p72SYK and B. M. M. PubMed Google Scholar, 1995; PubMed Scopus Google Scholar, M. 1997; PubMed Google Scholar). a C-type lectin from GPVI/Fcγ to activate platelets via a tyrosine phosphorylation pathway M. 1997; PubMed Scopus Google Scholar). or not aggretin the GPVI/Fcγ the of aggretin platelets from mice were with those normal platelets binding of fibrinogen was to the activation of as a of platelet with convulxin, a the of platelets with a activation of the control the platelets were not activated with the Fcγ-deficient platelets those by PubMed Scopus Google as well as with and platelets B. M. M. PubMed Google and that via M. 1997; PubMed Scopus Google Scholar). the of platelets from both of mice although the normal platelets the Fcγ-deficient platelets that is expressed or that via these receptors is by the of the Fcγ pathway. of platelet also in response to of both the Fcγ-deficient platelets and the normal platelets to collagen were that activation was in were not neither Fcγ-deficient nor platelets B. M. M. PubMed Google to a from GPVI/Fcγ is for the response to with as well as with antibodies not confirmed the Fcγ-deficient of these and PubMed Scopus Google that an in activation of platelets via with antibodies to α2β1. platelets not PubMed Scopus Google it is that receptor is in platelet activation by Fcγ-deficient platelets that they show to collagen M. 1997; PubMed Scopus Google including a activation of p72SYK and the of the is not to a these M. 1997; PubMed Scopus Google did not to collagen with the Fcγ-deficient the of platelets from a with also Fcγ M. M. 1997; PubMed Scopus Google the platelets also to collagen than normal platelets B. M. M. PubMed Google Scholar). was that the response of platelets to collagen to interactions with M. PubMed Scopus Google that of Fcγ-deficient platelets and that to a affinity binding to α2β1 was not inhibited by M. PubMed Scopus Google Scholar). B. PubMed Scopus Google binding to α2β1 in an or in with α2β1 binding to of aggretin and are or with the N-terminal sequences is not platelets by was to platelets with convulxin, the activation of is a of the of M. 1997; PubMed Scopus Google in the activation of was by and is a primary of the aggretin and α2β1 and is α2β1 is or to activated by to This is to with collagen of sequences that with the PubMed Scopus Google is the for interactions in primary it was that the platelet α2β1 and is activated via interactions with platelet activation via GPVI/Fcγ may to α2β1 to it to to of platelets to the the may high it may the receptor that platelet activation via to collagen to α2β1 of a of activation from the with the platelets from the collagen is to a other collagen including may in platelet activation pathway by both collagen and was to phosphorylation of to activation of p72SYK and of for α2β1 in activation of of by was also by using antibodies and PubMed Scopus Google and 1997; PubMed Google that α2β1 via of a these are by the use of collagen as interactions with than receptor or by the use of antibodies a of was that aggretin or may provide a for via α2β1. aggretin to both α2β1 and GPIb the the of other receptors in of α2β1 it as collagen is aggretin is an with than binding for platelet that binding and of α2β1 may not to activate and GPIb or the of is to of activation with activation of p72SYK and of not Fcγ with p72SYK. of a for Fcγ in the platelet response to aggretin supports the using platelets from Fcγ-deficient mice the activation response to aggretin was than that with platelets from control Aggretin, by and α2β1 and a response in This supports a major for α2β1 in platelet activation as binding to and activated platelets S.M. M. PubMed Scopus (106) Google although is a binding to is in activated the of collagen is a for GPVI/Fcγ in platelets in binding collagen not the platelet response to collagen, α2β1 with GPVI/Fcγ and and the response to receptor. This is in the of the platelet response to with α2β1 a number of to to activated by from other receptors to and fibrinogen platelets to and activated by a surface PubMed Scopus Google a in the of to activation of Fcγ the for is not 1997; PubMed Scopus Google Scholar). Aggretin of α2β1 and GPIb to a pathway that may to several of aggretin as a platelets via α2β1 and GPIb of of the from these with for as M. 1997; PubMed Scopus Google or 1995; PubMed Scopus Google it provide the to these major receptors in platelet We the of the in for the of We are to the for the of antibodies and

References

41